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Nemo-like kinase regulates the 
expression of vascular endothelial 
growth factor (VEGF) in alveolar 
epithelial cells
Hengning Ke1, Katarzyna Chmielarska Masoumi1, Kristofer Ahlqvist1, Michael J. Seckl2, 
Kristina Rydell-Törmänen3 & Ramin Massoumi1
The canonical Wnt signaling can be silenced either through β-catenin-mediated ubiquitination and 
degradation or through phosphorylation of Tcf and Lef by nemo-like kinase (NLK). In the present study, 
we generated NLK deficient animals and found that these mice become cyanotic shortly before death 
because of lung maturation defects. NLK−/− lungs exhibited smaller and compressed alveoli and the 
mesenchyme remained thick and hyperplastic. This phenotype was caused by epithelial activation of 
vascular endothelial growth factor (VEGF) via recruitment of Lef1 to the promoter of VEGF. Elevated 
expression of VEGF and activation of the VEGF receptor through phosphorylation promoted an increase 
in the proliferation rate of epithelial and endothelial cells. In summary, our study identifies NLK as a 
novel signaling molecule for proper lung development through the interconnection between epithelial 
and endothelial cells during lung morphogenesis.
Lung development is a complex process requiring interplay between different cell types, which communicate 
through specific and regulated signaling pathways1. Inappropriate lung development causes diverse lung diseases 
including cystic fibrosis and asthma, and may contribute to chronic obstructive pulmonary disease (COPD)2. 
Similar to humans, lung development in mice is regulated by growth factors expressed by the epithelium or stro-
mal cells, which in turn activate receptors in a paracrine or autocrine manner. Gene transcription mediated by 
receptor activation regulates the growth and differentiation of all compartments of the lung3,4. Wnt signaling is 
one of the most important pathways orchestrating normal lung development in mice and humans5.
The Wnt pathway is involved in different cellular process, such as cell fate decisions, stem cell self-renewal, 
cell proliferation, and differentiation. The importance of Wnt signaling was demonstrated by mutations in con-
stituent steps, which cause developmental defects in mice6. In response to canonical Wnt binding to its receptors, 
β -catenin translocates from the cytosol to the nucleus, binds directly to the transcription factors T-cell factor 
(Tcf) and lymphoid enhancing factor (Lef), and activates transcription of Wnt target genes such as c-Myc and 
cyclin D17,8. β -catenin, Tcf1-4, and Lef1 are all expressed in different lung cell types including the primordial epi-
thelium (PE), alveolar epithelium (AE), and adjacent mesenchymal cells9. Mice harboring tissue-specific deletion 
of β -catenin in lung epithelial cells die at birth because of respiratory failure. This phenotype has been explained 
by disrupted lung morphogenesis, lack of differentiation of the peripheral lung, and enhanced formation of the 
conducting airways10. Lung-endoderm-specific expression of constitutively active β -catenin-Lef1, promotes 
uncontrolled proliferation and a lack of differentiation in lung cells11. Furthermore, deletion of Wnt5a causes 
hyperthickening of the mesenchymal interstitium and overbranching of the epithelial airway12, whereas overex-
pression of Wnt5a in the lung epithelium disrupts epithelial-mesenchymal interaction and causes malformations 
in both the airway epithelium and the surrounding mesenchyme13.
Nemo-like kinase (NLK) is a kinase activated by phosphorylation14 and is involved in differentiation and 
embryogenesis in C. elegans, Xenopus, and Drosophila15–18. Previous studies have demonstrated a tumor suppres-
sor function of NLK, through regulating proliferation and cell survival of tumor cells originating from the breast, 
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liver, gallbladder, and colon19–22. Upon activation, NLK can phosphorylate several proteins essential for the reg-
ulation of IL-6, Notch, and canonical Wnt/β -catenin signaling15,16,23–26. The negative regulation of Wnt signaling 
by NLK is mediated via the phosphorylation of Tcf/Lef. Phosphorylation of this complex by NLK prevents the 
recruitment of Tcf/Lef to DNA and facilitates ubiquitination and degradation of the complex15.
In the present study, we generated NLK deficient mice and found that these mice had a severe phenotype with 
a very short lifespan, i.e. they die within 12–36 hours after birth. The reason for this phenotype was found to be 
an abnormal pulmonary architecture, with a skewed balance between endothelial and epithelial development. 
More precisely, CD31-positive endothelial cells showed elevated proliferation and hyperplasia caused by alveolar 
epithelial cell-dependent aberrant expression of VEGF.
Results
To explore the function of NLK in vivo, we generated NLK-deficient mice by inserting a lacZ reporter gene 
upstream of the exon 2 of NLK gene (Supplementary Fig. S1). We confirmed the absence of NLK mRNA and 
protein in mouse embryonic fibroblasts by Western blot and RT-PCR analyses (Fig. 1A). In the lung, brain, and 
kidney tissues of new born mice, NLK showed the highest expression compared to other tissues tested (Fig. 1B,C). 
Immunohistochemistry, Western blot, and RT-PCR analyses confirmed the absence of NLK expression in the 
lungs and brains of NLK deficient mice (Fig. 1D and Supplementary Fig. S2A,B). Immunohistochemical analysis 
also provided evidence that NLK is mainly localized in the nucleus of cells isolated from lung or brain tissues in 
wild type animals using NLK antibodies (Supplementary Fig. S2A,B), whereas β -gal expression was only detected 
in the lung and brain tissues isolated from NLK knockout animals (Supplementary Fig. S2A,B).
NLK deficient animals had a severe phenotype with a short lifespan. All of the NLK deficient mice were alive 
at birth but they died within 12–36 hours after birth (Fig. 2A,B). Most of the heterozygous mice had no obvious 
phenotype (Fig. 2A). Examination of newborn NLK− /− mice showed that these animals were smaller than nor-
mal: average birth weight was only 72% of the average birth weight of their control littermates (Fig. 2C). Although 
their lungs inflated well with air at birth (Supplementary Fig. S3), many NLK− /− mice became cyanotic shortly 
before death (Fig. 2B, right panel). In our system, we took the advantage of FRT sequence around the introduced 
stop codon to ensure that the observed phenotype was dependent on NLK deletion (Supplementary Fig. S1). 
Crossing heterozygous NLK mice with FRT mice resulted in the removal of the stop codon from knockout ani-
mals which rescued the expression of NLK. These mice (FRTNLK) were healthy and could survive for up to one 
year without any obvious phenotype.
Compromised lung development might be a contributing factor to the lethal cyanotic phenotype of NLK− /− 
mice. To test this hypothesis, we performed a histological analysis of NLK+ /+ and NLK− /− mouse lungs (P1) 
to determine the impact of the ablation of NLK on lung architecture. By P1, NLK+ /+ mouse lungs showed 
Figure 1. Generation of NLK deficient animals. (A) The insertion of the stop cassette was shown by 
genotyping analysis of wild type and NLK knockout mice (Left top panel). RT and qRT-PCR of total RNA from 
mouse embryonic fibroblast isolated from E 13.5 wild type and NLK knockout mice. GADPH was used as a 
loading control. (B,C) Protein and mRNA expression levels of NLK in wild type mouse tissues including lung, 
brain, skin, kidney, and liver. The blot in figure (C) has been cut in two pieces and blotted against NLK or actin 
under the same experimental conditions. (D) Protein and mRNA expression levels of NLK expressed in lung 
tissues at birth (P1) of wild type and NLK knockout mice. The blot in this figure has been cut in two pieces and 
blotted against NLK or actin under the same experimental conditions.
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well-inflated alveoli and the mesenchyme had thinned out. However, NLK− /− lungs exhibited smaller and 
compressed alveoli and the mesenchyme remained thick (Supplementary Fig. S4). Higher magnification images 
showed a disorganized alveolar structure and thick alveolar walls (Supplementary Fig. S4). Next, we analyzed 
lung tissues isolated from embryos at E18.5. Much smaller alveoli with irregular morphology in knockout animals 
compared to NLK wild type mice were observed at E18.5, E20.5, and P1 (Fig. 3A,B). Quantification showed a 
reduction in the chord length (Fig. 3C) and increased thickness of the alveolar capillaries (Fig. 3D) in NLK− /− 
mice compared to wild type animals.
The phenotype of lungs from NLK deficient mice could be due to decreased apoptosis and/or increased 
proliferation. To determine the extent of apoptosis in NLK+ /+ and NLK− /− lungs, we performed TUNEL 
staining of E18.5 lung tissues. This experiment revealed that the loss of NLK did not grossly affect cell survival 
(Fig. 4A). To examine cell proliferation, we compared BrdU, Ki67 and cyclin D1 expression between NLK+ /+ 
and NLK− /− lung sections isolated from E18.5 embryos. NLK− /− lungs displayed a significant increase in all 
three proliferation markers compared to lung sections from wild type animals (Fig. 4B,C and Supplementary 
Fig. S5). To distinguish cell type specificity, we investigated proliferation status of pulmonary epithelial and 
endothelial cells. Higher number of proliferating alveolar epithelial type II (Fig. 4D, left panel) and endothelial 
cells (Fig. 4D, right panel) isolated from knockout mice compared to wild type animals could be observed. This 
result was confirmed using lung sections isolated from E18.5 embryos and stained for pro-surfactant protein C 
(proSP-C) positive alveolar epithelial type II and endothelial cells (Fig. 4E and (Supplementary Fig. S6). We could 
not observe any significant differences in the proliferation of aquaporin-5 (AP-5) positive alveolar epithelial type 
I cells comparing wildtype with NLK deficient mice (Supplementary Fig. S6). To analyze whether NLK regulates 
Wnt-mediated proliferation through the phosphorylation of Lef1, we performed immunofluorescent staining 
of lung tissues using phosho-Lef1 antibodies. No differences in the total number of Lef1 positive cells could be 
observed, whereas the number of phospho-Lef1 positive cells was three times higher in wild type mice compared 
to NLK deficient lung tissues (Fig. 4F,G). In wildtype tissue we found a negative correlation between cells positive 
for proliferation marker (Ki67) and Lef1 phosphorylation (Fig. 4H). Furthermore, wildtype isolated pulmonary 
epithelial but not endothelial cells showed higher levels of Lef1 phosphorylation compared with NLK deficient 
cells (Fig. 4I). Taken together, these results suggest that deletion of NLK promotes proliferation of pulmonary 
cells through the Lef signaling pathway operating in epithelial cells.
In addition to the hyperthickening of the lung vasculature in knockout compared to wild type tissues (Fig. 5A) 
lung tissues isolated from wild type and NLK deficient animals, showed a significant differences in the levels of 
vascular endothelial growth factor (VEGF) mRNA at E18.5 and P1 (Fig. 5B). VEGF isoform 188 compared to 
120 and 164 was highly expressed in NLK− /− lung sections isolated from P1 (Supplementary Fig. S7). This is in 
agreement with previous study showing that VEGF188 is highly expressed in alveolar cells in the mouse during 
Figure 2. NLK deficient animals have a severe phenotype with a short lifespan. (A) The survival rate of wild 
type (n = 74), heterozygous (n = 123) and NLK knockout mice (n = 59) between postnatal day 1 and day 3. 
(B) Images of NLK+ /+ (WT) and NLK− /− (KO) mouse 24 hours (left panel) and 36 hours (right panel) after 
birth. (C) Relative birth weight of wild type NLK and NLK− /− pups.
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development27. Epithelial cells isolated from knockout animals secreted higher levels of VEGF-A compared to 
wild type cells (Fig. 5C). Endothelial cells also secreted VEGF-A, but at lower levels compared to epithelial and 
no differences in VEGF expression could be observed comparing wild type and NLK knockout cells (Fig. 5D). 
Furthermore, immunofluorescent staining using antibodies recognizing the active form of VEGF receptor-1 
(VEGFR-1) or VEGFR-2 showed increased numbers of cells harboring phosphorylated VEGFR-2 (Fig. 5E) in 
both epithelial and endothelial NLK deficient cells (Supplementary Fig. S8). The staining of VEGFR1 phospho-
rylation was weak (Supplementary Fig. S9), suggesting that VEGFR-2 activation is the major VEGF receptor 
mediating downstream signaling.
To determine the transcriptional elements necessary for VEGF-A upregulation, we overexpressed deletion 
mutants of the VEGF-A promoter using a luciferase reporter or the promoterless construct (pGL2-basic) con-
taining only the firefly luciferase-reporter in two different immortalized human alveolar cell lines, i.e. P2G and 
P2GH28,29. Luciferase activity was observed for all VEGF-A promoters tested, but the 1.6 kb deletion mutant 
showed the highest activity, suggesting that this region contains regulatory elements for VEGF-A expression 
(Fig. 6A). Indeed, epithelial cells isolated from knockout animals showed higher levels of VEGF-A promoter 
activity compared top wild type cells using 1.6 kb deletion mutant (Fig. 6B). In this region, 1394 bp before the start 
codon, we could identify Tcf binding element (TBE) (Supplementary Fig. S10; labeled in red). Overexpression of 
wild type NLK but not the catalytic mutant NLK (NLK-K155M) in P2G and P2GH cells reduced the promoter 
activity of VEGF-A, suggesting that activation of NLK is necessary for this effect (Fig. 6C). Furthermore, chroma-
tin immunoprecipitation using epithelial cells showed that overexpression of NLK, but not NLK-K155M, reduced 
the binding of Lef1 to the VEGF-A promoter in human alveolar P2GH cells (Fig. 6D). These results suggest that 
expression of VEGF-A by epithelial cells is regulated by the activation of NLK.
Figure 3. Smaller alveoli with irregular morphology and hyperplastic in NLK−/− compared to wild type 
mouse. (A) H&E-stained lung sections from E18.5, E 20.5, and P1 isolated form NLK+ /+ and NLK− /− mice. 
(B) H&E-stained lung sections show the different appearance of alveolar septum between NLK+ /+ and 
NLK− /− mice at P1. (C) The mean chord length of alveoli in NLK+ /+ and NLK− /− mice at P1. (D) The 
thickness of the alveolar capillary wall in NLK+ /+ and NLK− /− mice at P1.
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Discussion
Wnt receptor activation via β -catenin and Tcf/Lef is involved in different aspect of mouse and human tissue 
development30. Beside degradation of β -catenin via proteasome, this signaling pathway can be antagonized by 
NLK. In the present study, we investigated whether degradation of β -catenin via proteasome overrides the func-
tion of NLK for limitation of Wnt signaling. We found that deletion of NLK leads to shorter lifespan, where the 
pups succumb within 12–36 hours after birth, and this was caused by a respiratory phenotype causing breathing 
problems. The newborn NLK deficient mice were smaller than normal and became cyanotic shortly before death. 
Investigating tissue specific expression of NLK, we found the highest NLK levels in lungs and brain of new born 
mice. Recently, it was shown that generation of NLK-deficient mice provided a phenotype that varied with the 
genetic background31. In our system crossing heterozygous NLK mice with FRT mice resulted in removal of stop 
codon from the knockout animals and prolonged their survival to one year of age.
The phenotype of NLK deficient mice is caused by smaller and compressed alveoli as well as thick and edema-
tous alveolar walls, which could be explained by an increase in cell proliferation. Previously it has been shown 
that NLK is negatively regulate Wnt/β -catenin signaling by phosphorylation of the complex Tcf/Lef and pre-
venting DNA association of these transcription factors23. Since we found a negative correlation between prolif-
eration and Lef1 phosphorylation in wild type mice, this suggests that, in the absence of NLK, inactivation and 
Figure 4. Increased cell proliferation in NLK−/− lung sections compared to wild type animals. (A) TUNEL 
staining and quantification of the number of positive cells in NLK+ /+ and NLK− /− lung tissues at P1. (B) Cyclin 
D1 staining and quantification of the number of positive cells in NLK+ /+ and NLK− /− lung tissues at P1.  
(C) Ki67 staining and quantification of the number of positive cells in NLK+ /+ and NLK− /− lung tissues at P1. 
(D) Measurement of the growth rate of NLK+ /+ and NLK− /− primary murine alveolar epithelial (left panel) 
and endothelial cells (right panel) over a period of 24–72 hours using MTS assay. (E) Double staining of PCNA 
and CD31 or PCNA and proSP-C in NLK+ /+ and NLK− /− lung tissues at P1. (F) Immunofluorescence staining 
of total Lef1 and phospho-Lef1 positive cells in the lung sections isolated from NLK+ /+ and NLK− /− at P1.  
(G) Quantification of the number of phospho-Lef1 positive cells among Lef1 positive cells in the lung sections 
isolated from NLK+ /+ and NLK− /− at P1. (H) Quantification of the number of Ki67 positive cells among 
phospho-Lef1 positive cells in the lung sections isolated from NLK+ /+ at P1. (I) The levels of total Lef1 and 
phospho-Lef1 in NLK+ /+ and NLK− /− primary murine alveolar epithelial and endothelial cells. The blot in this 
figure has been blotted against pLef1. The membrane has been stripped and used again for blotting against total 
Lef1 under the same experimental conditions.
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phosphorylation of Lef1 is disrupted. Non-phosphorylated Lef1, in a complex with β -catenin and Tcf, promotes 
the transcriptional activation of target genes including cyclin D1, which causes an increase in the proliferation 
rate of cells. Previous studies have demonstrated that low NLK expression is an independent prognostic factor for 
the survival of patients suffering from non-small cell lung cancer (NSCLC). Moreover, in cell culture, downregu-
lation of NLK resulted in significantly increased proliferation in NSCLC cells through the transcriptional activity 
of the Wnt signaling pathway via β -catenin and Tcf/Lef activation32.
Aberrant expression of VEGF has been linked to several lung diseases, including acute lung injury, severe 
pulmonary hypertension, and emphysema33. Expression and synthesis of VEGF is controlled by several signaling 
pathways. VEGF and VEGFR are expressed during embryogenesis and VEGFR signaling plays an essential role 
in lung development33,34. The main receptors of VEGF-A is VEGFR-1 and VEGFR-2. Activation of VEGFR-2 has 
been shown to mediate mitogenic signal35, whereas VEGFR-1 activation is believed to act as a decoy receptor 
by inhibiting VEGF binding to VEGFR-236–38. However, it has not yet been established whether lung alveolar 
epithelial cells can regulate VEGF-A through Wnt signaling, and furthermore which region in VEGF-A pro-
moter recruits Lef1. We could identify part of the VEGF promoter, to which Lef1 was recruited and promoted an 
increase in the expression of VEGF. We could also show that the activation of NLK was necessary for repressing 
the activation of the VEGF promoter since overexpression of a catalytically inactive mutant of NLK in knockout 
cells was unable to prevent the association of Lef1 to the VEGF promoter or decreased VEGF promoter activ-
ity. Our results suggest that Wnt-induced NLK activation and subsequent Lef1 phosphorylation repress VEGF 
expression during embryogenesis; this pathway is pivotal for correct lung development. Previously it has been 
demonstrated that deletion of Wls (receptor protein directing Wnt ligands from the Golgi to the cell surface) from 
the embryonic pulmonary inhibits growth and differentiation of peripheral lung as well as formation of the pul-
monary vasculature. In this pathway, epithelial Wls was required for appropriate expression of essential regulators 
of vascular development including VEGF-A39.
In the present study, we found that in the absence of NLK led to aberrant expression of VEGF via β -catenin-Tcf 
signaling in lung epithelial cells (Fig. 6E). The expression of VEGF-A promotes the proliferation of pulmonary 
cells and vascular hyperthickening. In NLK-deficient animals, the disrupted Wnt balance causes cellular hyper-
plasia and thickened alveolar walls during lung morphogenesis that together leading to limited survival of these 
animals.
Figure 5. Hyperthickening of the lung vascularization and VEGF-A expression. (A) H&E-stained lung 
sections from showing hyperthickening of the lung vascularization in lung sections from NLK+ /+ and 
NLK− /− . (B) The levels of VEGF-A at the mRNA levels in NLK+ /+ and NLK− /− lung tissues isolated 
from E18.5 and P1. (C) The levels of secreted VEGF in the culture media of NLK+ /+ and NLK− /− primary 
epithelial cells. (D) The levels of secreted VEGF in the culture media of NLK+ /+ and NLK− /− primary 
pulmonary endothelial cells. (E) Immunofluorescence staining and quantification of phosphorylated VEGF 
receptor 2 (VEGFR2) in lung sections isolated from NLK+ /+ and NLK− /− at P1. Heat-mediated antigen 
retrieval in high pH buffer was performed before labeling. Data is given as fraction labeling (%); percentage 
positively labeled area of the total lung tissue area.
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Methods
Generation of knockout mice. NLK knockout (KO or NLK− /− ) mice were generated by inserting a cas-
sette containing lacZ reporter gene upstream of exon 2 of the NLK gene. This construct also contains a short loxP 
sequence inserted up- and downstream of exon 2, creating a floxed gene (Supplementary Fig. 1). In addition, 
this construct contains FRT sequences flanking the stop codon. Crossing of NLK+ /− mice with mice bearing 
an introduced Flp gene led to the removal of the flanked cassette containing the splice receiver, thus redirecting 
the splicing to exon 2 and restore the expression of NLK in their NLKfl/fl (Supplementary Fig. S1). All mice 
were maintained in specific pathogen-free housing at the Clinical Research Centre in Malmö, and the animal 
experiments were performed according to the national and international guidelines of the European Union. 
Furthermore, all experimental protocol was approved by Swedish regional (Malmö-Lund) ethical committee 
(application number: M336-12).
Mice were weighted instantly after birth with a scale and observed for life span every two hours. Life time was 
recorded as the time between the death time point found and the birth time found.
Mice were genotyped using primers:
NLKForward 5′ -GGGACTTCAGAGACAGGGAAC-3′ 
NLKReverse 5′ -CTGGAAGACGTTGGGCATC-3′ 
LacZForward 5′ -GCATCGAGCTGGGTAATAAGCGTT-3′ 
Figure 6. Recruitment of Lef1 to the promoter of VEGF-A. (A) Luciferase activity in human lung epithelial 
cells P2GH (left panel) and P2G (right panel) using deletion mutants of VEGF promoter. Control (Ctrl): cells 
without transfection with luciferase expression plasmid. (B) VEGF promoter luciferase activity (1,6 kb) in 
primary isolated mouse lung epithelial cells. Control (Ctrl): cells without transfection with luciferase expression 
plasmid. (C) Luciferase activity in human lung epithelial cells P2GH (left panel) and P2G (right panel) using 
deletion mutant of VEGF promoter (1,6 kB) in cells transfected with Full length (FL-NLK), catalytically 
inactive mutant of NLK (KM-NLK), or empty expression vector (Ctrl). (D) Recruitment of Lef1 to the VEGF-A 
promoter by ChIP using human lung epithelial cells (P2GH) transfected with Full length (FL-NLK), catalytically 
inactive mutant of NLK (KM-NLK), or empty expression vector (Ctrl). IP: Lef1 indicates immunoprecipitation 
(IP) using polyclonal antibodies. IP: IgG, IP using pre-immune serum. Input: 10% of the cell lysate used for the 
IP is shown. (E) Model of how deletion of NLK leads to elevated levels of VEGF expression causing aberrant 
proliferation of pulmonary epithelial and endothelial cells (left). In the wildtype epithelial cells, NLK mediated-
phosphorylation of Lef1 prevents the binding of Lef1 to the promoter of VEGF (right).
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LacZReverse 5′ -GACACCAGACCAACTGGTATTGG-3′ 
FRTForward 5′ -AAA GTC GCT CTG AGT TGT TAT-3′ 
FRTReverse 5′ -GCG AAG AGT TTG TCC TCA ACC-3′ 
Human alveolar cells. Human alveolar type II pneumocytes were isolated from human lung resection 
specimens29 and immortalized by transduction with the catalytic subunit of telomerase and simian virus 40 
large-tumor antigen as previously described28. The methods involving human tissue were carried out in accord-
ance with the approved guidelines. Local institutional review board approval was given for the anonymous col-
lection of lung tissue. Ethical approval was obtained from the Brompton, Harefield, and NHLI Ethics Committee, 
and patients gave informed consent.
Isolation of primary murine alveolar epithelial, endothelial cells and ELISA assay. Isolation of 
primary murine type II alveolar epithelial cells40 and isolation and culture of pulmonary endothelial cells from 
neonatal mice41 were performed as previously described.
The analysis of mouse VEGF expressed in cell culture was performed by using VEGF Quantikine ELISA Kit 
(MMV00, R&D systems) according to manufactures descriptions.
Determination of alveolar airspace size, number of primitive alveoli and number of alveolar 
septa. The size of the alveolar airspace was determined by measuring mean chord lengths on H&E-stained 
lung sections (Bry et al., 2007). Images were taken from five representative non-overlapping fields of lungs from 
at least eight mice. A grid consisting of six lines at 35 μm intervals was overlaid on the image. Areas of bronchiolar 
airways and blood vessels were eliminated from the analysis. The length of the lines overlapping the alveoli was 
measured and averaged to give the mean chord length of the alveolar space. The number of primitive alveoli and 
secondary alveolar septa was determined on H&E-stained E18.5 and P1 lung sections, respectively. Primitive 
alveoli of E18.5 lungs were identified as pouches or sacs with flattened epithelium radiating from the terminal 
airways. Secondary septa on P1 lungs were identified as the thin membranes that folded into the alveolar sac.
Chromatin immunoprecipitation. Chromatin immunoprecipitation was performed according to the 
manufacturer’s instructions (IMGENEX Corporation), using a rabbit polyclonal Lef1 antibody (Abcam). The 
extracted DNA was used for semi-quantitative PCR to amplify the promoter region of the VEGF gene harboring 
Tcf-Lef binding elements. The primer sequences used in real-time quantitative PCR were:
VEGF (prim8) Forward 5′ -CTTTAGCCAGAGCCGGGGT-3′ 
VEGF (prim8) Reverse 5′ -ACCAAGGTTCACAGCCTGAAA-3′ .
Statistical analyses. Statistical analyses were performed using GraphPad Prism5 Software (GraphPad 
Software, San Diego, CA, USA). Results are expressed as mean ± s.e.m. or as percentages. P-values < 0.05 were 
deemed statistically significant. Comparisons between groups were performed using the Mann-Whitney U test. A 
correlation analysis was performed by determining the Pearson product-moment correlation coefficient.
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